KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Resmed (RMD) EBT Margin (2016 - 2025)

Resmed's EBT Margin history spans 17 years, with the latest figure at 34.87% for Q4 2025.

  • For Q4 2025, EBT Margin rose 224.0% year-over-year to 34.87%; the TTM value through Dec 2025 reached 33.69%, up 254.0%, while the annual FY2025 figure was 32.6%, 560.0% up from the prior year.
  • EBT Margin reached 34.87% in Q4 2025 per RMD's latest filing, up from 33.45% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 34.87% in Q4 2025 to a low of 22.31% in Q4 2023.
  • Average EBT Margin over 5 years is 28.69%, with a median of 27.95% recorded in 2021.
  • Peak YoY movement for EBT Margin: tumbled -416bps in 2023, then skyrocketed 1032bps in 2024.
  • A 5-year view of EBT Margin shows it stood at 26.52% in 2021, then decreased by 0bps to 26.48% in 2022, then decreased by -16bps to 22.31% in 2023, then soared by 46bps to 32.63% in 2024, then rose by 7bps to 34.87% in 2025.
  • Per Business Quant, the three most recent readings for RMD's EBT Margin are 34.87% (Q4 2025), 33.45% (Q3 2025), and 33.98% (Q2 2025).